FdaApplication
ANDA 218491
Identifiers
- fda_app_no: ANDA218491
Properties
| Property | Value |
|---|---|
| applicant_name | SCIEGEN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2025-09-19 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| GABAPENTIN | GABAPENTIN | 300MG | TABLET;ORAL |
| GABAPENTIN | GABAPENTIN | 600MG | TABLET;ORAL |
2 products